Dswiss INC

Market Movers (8-K)

OID
Sui Ting Wong has resigned as a director of DSwiss, Inc., leaving Leong Ming Chia as the company's sole director.

Quarterly Earnings (10-Q)

OID
DSwiss, Inc. reported a significant decline in Q3 2025 revenue and an increased net loss, alongside negative operating cash flow and material weaknesses in internal controls, raising substantial doubt about its ability to continue as a going concern.
Capital raise
Worse than expected
OID
DSwiss, Inc. reported a significant revenue increase for the first half of 2025, but net income declined, raising going concern doubts and revealing material internal control weaknesses.
Capital raise
Worse than expected
OID
DSwiss, Inc. saw a significant increase in revenue for the three months ended March 31, 2025, but experienced a decrease in net profit compared to the same period in the previous year.
Worse than expected
OID
DSwiss Inc. saw a significant increase in revenue for the third quarter of 2024 compared to the same period last year, but still reported a net loss for the quarter.
Better than expected
OID
DSwiss Inc. saw a significant increase in revenue and a return to profitability in the first half of 2024, though material weaknesses in internal controls were identified.
Better than expected
OID
DSwiss Inc. reports a substantial increase in revenue and a swing to profitability in the first quarter of 2024, compared to a loss in the same period last year.
Better than expected

Annual Reports (10-K)

OID
DSwiss, Inc. reported a net loss of $76,860 for fiscal year 2025, a significant decline from the previous year's profit, raising substantial doubt about its ability to continue as a going concern.
Worse than expected
Capital raise
OID
DSwiss, Inc.'s 2024 annual report reveals a significant revenue increase but also identifies material weaknesses in internal control over financial reporting.
Better than expected
OID
DSwiss Inc. reported a decrease in revenue for the fiscal year 2023, alongside a net loss, while highlighting strategic initiatives in product development and market expansion.
Worse than expected
Capital raise